Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Polymyalgia Rheumatica Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Polymyalgia Rheumatica clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Giant Cell Arteritis Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Giant Cell Arteritis clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
ANCA-Associated Vasculitis Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 ANCA-Associated Vasculitis clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Idiopathic Inflammatory Myopathies Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Idiopathic Inflammatory Myopathies clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development…
Latest Hotspot
8 min read
Systemic Sclerosis Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Systemic Sclerosis clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Sjögren Disease Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Sjögren Disease clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Multiple Sclerosis Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Multiple Sclerosis clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Neuromyelitis Optica Spectrum Disorder Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Neuromyelitis Optica Spectrum Disorder clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development…
Latest Hotspot
8 min read
Myasthenia Gravis Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Myasthenia Gravis clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Eosinophilic Esophagitis Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Eosinophilic Esophagitis clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Celiac Disease Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Celiac Disease clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.
Latest Hotspot
8 min read
Crohn Disease Clinical Landscape Report 2026: Trials, Readouts and White Space
16 July 2026
2026 Crohn Disease clinical landscape covering trial endpoints, sponsors, phases, geographies, readouts, assets and development white space.